| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074225 Monomeric immunoglobulin Fc domains |
| 04/06/2006 | US20060074224 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074223 isolated antibody that binds specifically to the polypeptides; PRO polypeptide |
| 04/06/2006 | US20060074221 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074023 Angiogenesis associated proteins, and nucleic acids encoding the same |
| 04/06/2006 | US20060074009 Natriuretic compounds, conjugates, and uses thereof |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/06/2006 | US20060073575 Methods and reagents for assaying protein kinase activity |
| 04/06/2006 | US20060073570 Apo-2 receptor |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073562 Screening and identifying compounds compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway. |
| 04/06/2006 | US20060073558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073557 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073556 polypeptide that is an epitope tag or a Fc region of an immunoglobulin; used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060073555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073554 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073553 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073551 Pro4487 polypeptides |
| 04/06/2006 | US20060073550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073549 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073548 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073547 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073546 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073536 Immunoassays for determining vitamin B12, and reagents and kits therefor |
| 04/06/2006 | US20060073531 Anti-chlamydial antibodies and uses thereof |
| 04/06/2006 | US20060073528 Measurement methods |
| 04/06/2006 | US20060073526 Antibodies, assay method by using them and judgment method for pancreas cancer |
| 04/06/2006 | US20060073520 Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| 04/06/2006 | US20060073519 Antibody specific to interleukin 18 precursor |
| 04/06/2006 | US20060073517 Post-translational modifications of proteins as regulatory switches |
| 04/06/2006 | US20060073515 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| 04/06/2006 | US20060073498 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 04/06/2006 | US20060073477 Altered DNA synthesome components as biomarkers for malignancy |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073153 Individualized anti-cancer antibodies |
| 04/06/2006 | US20060073152 Therapeutic agents with decreased toxicity |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073149 Rapid improvement of cognition in condition related to abeta |
| 04/06/2006 | US20060073148 IL-13 binding agents |
| 04/06/2006 | US20060073147 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073144 Individualized anti-cancer antibodies |
| 04/06/2006 | US20060073143 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
| 04/06/2006 | US20060073142 Anti-Fc-gamma RIIB receptor antibody and uses therefor |
| 04/06/2006 | US20060073141 Compositions and methods for treating inflammatory disorders |
| 04/06/2006 | US20060073140 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 04/06/2006 | US20060073139 Vaccine composition for preventing meningococcal disease |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073135 Methods and compositions for modulating and detecting wisp activity |
| 04/06/2006 | US20060073116 Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | CA2581840A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | CA2575663A1 Antibodies directed against amyloid-beta peptide and methods using same |
| 04/06/2006 | CA2554718A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/05/2006 | EP1642987A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642910A1 Rationally designed antibodies |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 04/05/2006 | EP1642908A2 Apoptosis-induced site from fas ligand |
| 04/05/2006 | EP1642907A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642906A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642138A1 Secreted polypeptide species reduced in cardiovascular disorders |
| 04/05/2006 | EP1642132A2 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 04/05/2006 | EP1641919A2 Applications of a new class of enzymes: sulfiredoxines |
| 04/05/2006 | EP1641830A1 Emitter-binding peptides causing a change in the spectral emission properties of the emitter |
| 04/05/2006 | EP1641829A1 Emitter-binding peptides, which cause a modification of the spectral emission characteristics of the emitter |
| 04/05/2006 | EP1641828A2 Anti-hgf-r antibodies and their use |
| 04/05/2006 | EP1641827A2 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 04/05/2006 | EP1641826A2 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 04/05/2006 | EP1641822A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 04/05/2006 | EP1641816A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 04/05/2006 | EP1558644A4 A structured peptide scaffold for displaying turn libraries on phage |
| 04/05/2006 | EP1309701B1 Myrosinase from brevicoryne brassicae |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1049718B1 Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin |
| 04/05/2006 | EP0871673B1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety |
| 04/05/2006 | EP0618965B1 Method for generating structural and functional diversity in a peptide sequence |
| 04/05/2006 | CN1756844A Optimizing glycan processing in plants |
| 04/05/2006 | CN1756843A Streptococcus pyogenes antigens |
| 04/05/2006 | CN1756842A Branched neutral amino acid transporters acting as single molecule |
| 04/05/2006 | CN1756768A Trimeric polypeptide construct to induce an enduring t cell response |
| 04/05/2006 | CN1756767A Human heavy chain antibody expression in filamentous fungi |
| 04/05/2006 | CN1756764A Novel proteins and use thereof |